|
100
|
Medicinal Chemistry Support Program for Therapeutic Development (MCSP)
75N98026R00144SB · NATIONAL INSTITUTES OF HEALTH · NATIONAL INSTITUTES OF HEALTH NIDA · commercialization
|
biomedical clinical
computing communications
materials manufacturing
|
— |
2026-08-12 |
2026-09-14 |
8 |
|
100
|
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
75N98026R00109 · NATIONAL INSTITUTES OF HEALTH · NIH NCI · commercialization
|
biomedical clinical
cybersecurity
ai data science
|
— |
2026-07-10 |
2026-09-21 |
15 |
|
100
|
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
75N98026R00109 · NATIONAL INSTITUTES OF HEALTH · NIH NCI · commercialization
|
biomedical clinical
public health
computing communications
|
— |
2026-07-10 |
2026-09-21 |
15 |
|
100
|
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
75N98026R00109 · NATIONAL INSTITUTES OF HEALTH · NIH NCI · commercialization
|
biomedical clinical
public health
ai data science
|
— |
2026-07-24 |
2026-09-21 |
15 |
|
100
|
TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter
S-195061 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
public health
national security defense
|
— |
2026-06-15 |
2026-12-15 |
100 |
|
100
|
TECHNOLOGY LICENSING OPPORTUNITY: NanoFET
S-194657 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
public health
national security defense
|
— |
2026-06-17 |
2026-12-17 |
102 |
|
100
|
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
PA-27-102 · National Institutes of Health · commercialization
|
biomedical clinical
materials manufacturing
ai data science
|
— |
2026-05-28 |
2027-04-05 |
211 |
|
100
|
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
PA-27-100 · National Institutes of Health · commercialization
|
biomedical clinical
public health
materials manufacturing
|
— |
2026-05-28 |
2027-04-05 |
211 |
|
100
|
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
PA-27-101 · National Institutes of Health · commercialization
|
biomedical clinical
economic development
|
— |
2026-05-28 |
2029-04-05 |
942 |
|
100
|
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
PAR-27-098 · National Institutes of Health · commercialization
|
biomedical clinical
public health
materials manufacturing
|
— |
2026-05-28 |
2029-04-05 |
942 |
|
60
|
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
75A50126R00001_RFP_NPIVS_27 · OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE · BARDA - ASPR / DAAPPO / BARDA DCMA · commercialization
|
public health
biomedical clinical
emergency disaster resilience
|
— |
2026-08-17 |
2026-10-30 |
54 |
|
60
|
TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro
S-196061 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
ai data science
materials manufacturing
|
— |
2026-06-05 |
2026-12-05 |
90 |
|
60
|
TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform
S-191192 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
materials manufacturing
national security defense
|
— |
2026-06-15 |
2026-12-15 |
100 |
|
60
|
TECHNOLOGY LICENSING OPPORTUNITY: NanoFET
S-194657 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
public health
national security defense
|
— |
2026-06-17 |
2026-12-17 |
102 |
|
60
|
TECHNOLOGY LICENSING OPPORTUNITY: Selective Separation
S-167732 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
materials manufacturing
energy
agriculture food
|
— |
2026-04-07 |
2027-04-24 |
230 |
|
60
|
DEVCOM-SC BOTAA 22-01
DEVCOMBOTAA22-01 · DEPT OF THE ARMY · W6QK ACC-APG NATICK · commercialization
|
national security defense
materials manufacturing
biomedical clinical
|
— |
2022-06-09 |
2027-06-08 |
275 |
|
60
|
NSF National Innovation Corps Teams (NSF National I-Corps (TM) Teams) program
25-549 · U.S. National Science Foundation · commercialization
|
materials manufacturing
computing communications
energy
|
— |
2025-09-26 |
— |
— |
|
60
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG · commercialization
|
biomedical clinical
national security defense
public health
|
— |
2026-05-06 |
— |
— |
|
60
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG · commercialization
|
national security defense
biomedical clinical
public health
|
— |
2026-04-23 |
— |
— |
|
60
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
· DEPT OF DEFENSE · commercialization
|
national security defense
biomedical clinical
public health
|
— |
2026-04-23 |
— |
— |
|
45
|
TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform
S-191192 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
public health
biomedical clinical
|
— |
2026-06-15 |
2026-12-15 |
100 |
|
5
|
TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter
S-195061 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
public health
national security defense
|
— |
2026-06-15 |
2026-12-15 |
100 |